ARMGO Pharma, Inc., is a privately held biopharmaceutical company dedicated to applying targeted mechanism-based science to the development of novel small-molecule therapeutics to treat cardiac, musculoskeletal, and neurological disorders characterized by leaky Ryanodine Receptor (RyR) calcium channels.
DA:98PA:18MOZ Rank:67
ARMGO Pharma Inc - Company Profile and News - Bloomberg ...
ARMGO Pharma, Inc. manufactures pharmaceutical products. The Company develops and distributes small-molecule therapeutics for the treatment of debilitating cardiac, muscular, and neurological ...
DA:55PA:62MOZ Rank:3
ARMGO® Pharma Inc. Announces Clinical Trial of ARM210 ...
ARMGO Pharma, Inc., is a privately held biopharmaceutical company dedicated to applying targeted mechanism-based science to the development of novel small-molecule therapeutics to treat cardiac, musculoskeletal, and neurological disorders characterized by leaky Ryanodine Receptor (RyR) calcium channels.
DA:8PA:93MOZ Rank:100
ARMGO,Pharma,Inc. - Crunchbase Company Profile & Funding
ARMGO Pharma, Inc., a biopharmaceutical company, develops small-molecule therapeutics to treat debilitating cardiac, skeletal muscular, and neurological disorders. It offers rycals, which are calcium release channel stabilizers that act on ryanodine receptor/calcium release channel, a therapeutic target located on the ...
Armgo pharma, inc. is a firm based at 923 saw mill river rd, pmb 260, ardsley. it was set up as a foreign business corporation in new york county, under id number 3182815 on march 28, 2005, 15 years ago. this company is, at present, supervised by a chief executive officer - eugene marcantonio from tenafly.
Armgo Pharma Inc. AveXis Inc. Biogen Inc. Bioleaders Corp. ... heading for one of its worst days since the pandemic-spurred liquidation in March.The rout began just hours after Bitcoin rose to ...
DA:67PA:33MOZ Rank:45
List of bankrupt, sold, merged, or otherwise defunct ...
Merged with Espero Pharma, Mar 2017 Armgo Pharma: Website under construction, May 2020 - Dec 2020 ARMO BioSciences: Acquired by Lilly, July 2018, $1.6B Armour Therapeutics: Seems inactive, no employees on LI Armune Bioscience: Acquired by Exact Sciences, Dec 2017 Arno Therapeutics: Dissolved Dec 2017 Aronex Pharmaceuticals
DA:55PA:39MOZ Rank:14
Nova Biomedical BioProfile Flex 2 Automated Cell Culture ...
The majority of the items in the Armgo Auction were inventoried as part of a working lab (not in storage), unless otherwise noted. OncoMed Pharma. 800 Chesapeake Drive. Redwood City, CA 94063 . Notes from the Auction Team: As with all BioSurplus auctions, items are sold as-is, and are not tested prior to fulfillment. There is an intrinsic risk ...
DA:67PA:14MOZ Rank:46
Karen Katen, Director and Member of Compensation Committee ...
She also serves on the Economic Club of New York Board of Trustees. She is a Trustee at the University of Chicago. She serves as Director of ARMGO Pharma, Inc. She serves as Honorary Director of Catalyst Inc. and served as its Director. She served as a Director of Motors Liquidation Company from 1997 to July 2009.
